CA-EBD/BIO-EUROPE-2014
The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center.
“BIO-Europe has continued to be the leading European life science partnering event because of the high caliber companies that bring their teams to partner,” said Florian Schoenhammer, Group Managing Director, EBD Group. "In fact, this year we are celebrating the 20th anniversary of the event which has grown from just 97 attendees in 1995 to over 3,200 in 2013. The reason for this growth is simply that it continues to successfully facilitate dealmaking in the industry."
BIO-Europe is organized by EBD Group in collaboration with local hosts, the Hessian Ministry of Economic, Transport, Urban and Regional Development, aka Hessian Biotech; Hessen Trade & Invest; and the Cluster for Individualized ImmuneIntervention (Ci3), the City of Mainz and the State of Rhineland Palatinate.
Register for BIO-Europe before August 31 to receive a discount of EUR 200.
Highlights of the event are focused around partnering opportunities between leading dealmakers from biotech, pharma and finance, as well as a presenting companies track which provides direct access to innovative new drugs and technologies. The 2013 edition featured 184 company presentations from biotech and midsize pharma companies, next generation companies representing early stage projects and small entrepreneurial companies, and academic innovators.
The program of panels and workshops features industry thought leaders and executives speaking on topics relevant to industry decision makers. In addition to the regular program, there are featured pre- and post-events at BIO-Europe, including the Advanced Business Development Course, the China Forum, and an offering from Pharmaceutical Licensing and Collaboration Agreements: Legal Partnering. More information is available online .
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. Companies participate in one-to-one partnering meetings facilitated by EBD Group’s highly reputable partneringONE® platform.
The 2013 edition featured 17,874 one-to-one partnering meetings, an all-time record. Over 3,200 delegates from 1,841 companies representing 56 countries attended. There were 184 company presentations with close to 3,600 licensing opportunities on offer, and 95 exhibitors at the event.
About BIO-Europe ® 2014:
The 20th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.
Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.
Follow BIO-Europe 2014 on Twitter: twitter.com/ebdgroup (hashtag: No. BEU14). Or log on to the Life Science Partnering discussion forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe ® and BIO-Europe Spring ®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America ™, the fastest growing partnering event in North America
- Biotech Showcase ™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe , the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum , the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech ™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum ™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140812005834/en/
Contact:
EBD Group
Erin Righetti
+1-760-930-0500
erighetti@ebdgroup.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
IFF to Release First Quarter 2025 Results on May 6, 202514.4.2025 22:15:00 CEST | Press release
IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook. View source version on businesswire.com: https://www.businesswire.com/news/home/20250414046211/en/
BM3EAC Corp. 2024 Annual Report14.4.2025 18:05:00 CEST | Press release
BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its annual report for the period 1 January 2024 to 31 December 2024. The annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER The Company’s annual report referenced in this announcement may include forward-looking statements, which are based on the Company's current expectations and projections regarding a business combination, the business, the economy and other future conditions of the Company and speak only as of the date hereof. Forward-looking statements may and often d
Canoga Perkins' SyncMetra® Network Connectivity Solution Enables Enterprise AI at the Edge, Powered by AMD FPGAs14.4.2025 17:00:00 CEST | Press release
Software-defined, guaranteed low-latency connectivity available for enterprise AI and industrial automation use cases Network connectivity solutions provider, Canoga Perkins today announced that its SyncMetra ultra-low, guaranteed latency offering for enterprise AI at the edge is powered by AMD Virtex™ UltraScale+™ FPGAs. SyncMetra is Canoga Perkins' software-defined, IT-operated private 5G network transport solution that guarantees ultra-low latency, deterministic wireless communications for enterprise AI, industrial automation, and AR/VR applications. Providing performance and features that enable inference to take place on-premise, consolidating multiple sensor feeds and reducing total cost of ownership—the SyncMetra unlocks a new breed of Enterprise Edge AI applications. Programmable, expandable, and software-defined, SyncMetra operates via a cloud-managed network orchestrator (SyncMetra Manager), access points, a SyncMetra switch, and a 5G operating system or core. This allows net
Illumynt Announces Completion of Supercomputer Decommission Project14.4.2025 16:00:00 CEST | Press release
CNE Direct, Inc., dba Illumynt, is pleased to announce we successfully completed a high-profile decommission project for one of the largest global supercomputer installations during the month of March. We received, tested, and resold thousands of AI-optimized full server racks and harvested components, generating sales proceeds in excess of our original estimates for the project. “Our recent success is mostly due to our increased focus on services offered to data centers and other enterprise organizations. AI and machine learning are requiring aggressive upgrades in hardware, resulting in previous technology to be outdated early and creating multiple opportunities for illumynt,” said CEO Paul Knight. Illumynt’s facilities in Columbus, OH, Memphis, TN, Amsterdam, and Hong Kong are running at high capacity and expanding every month - along with our co-location units in Franklin, MA, Cork, Ireland, and Chon Buri, Thailand. As a result of the decommission project and scaling of other globa
Rimini Street to Report First Quarter 2025 Financial Results on May 1, 202514.4.2025 15:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on May 1, 2025. The company will host a conference call and webcast on that date to discuss the first quarter 2025 results and the 2025 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250414870291/en/ Rimini Street to Report First Quarter 2025 Financial Results on May 1, 2025 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum